Inflammation & Allergy - Drug Targets (Discontinued)
Title:ACKNOWLEDGEMENTS TO THE REVIEWERS
Volume: 13 Issue: 6
Export Options
About this article
Cite this article as:
ACKNOWLEDGEMENTS TO THE REVIEWERS, Inflammation & Allergy - Drug Targets (Discontinued) 2014; 13 (6) . https://dx.doi.org/10.2174/187152811306150615151128
DOI https://dx.doi.org/10.2174/187152811306150615151128 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Journals
Related Books
15
Related Articles
-
Editorial (Another Year of Prosperity for Current Molecular Medicine)
Current Molecular Medicine Vasorelaxation Caused by Cannabinoids: Mechanisms in Different Vascular Beds
Current Vascular Pharmacology Transcranial Direct Current Stimulation for the Treatment of Addictions: A Systematic Review of Clinical Trials
Current Psychiatry Reviews Pleuroparenchymal Fibroelastosis: Its Clinical Characteristics
Current Respiratory Medicine Reviews Influence of Mutations in the Hepatitis B Virus Genome on Virus Replication and Drug Resistance - Implications for Novel Antiviral Strategies
Current Medicinal Chemistry Role of the Microenvironment in Tumourigenesis: Focus on Virus-Induced Tumors
Current Medicinal Chemistry Adenosine and Sleep
Current Neuropharmacology The role of vitamin D towards immune tolerance in white adipose tissue (WAT)
Endocrine, Metabolic & Immune Disorders - Drug Targets The Early Involvement of the Innate Immunity in the Pathogenesis of Lateonset Alzheimers Disease: Neuropathological, Epidemiological and Genetic Evidence
Current Alzheimer Research Nitric Oxide and L-Arginine Deficiency in Cystic Fibrosis
Current Pharmaceutical Design Therapy Related Markers and Response Prediction Towards Multimodal Treatment of Carcinomas of the Upper Gastrointestinal Tract
Current Pharmacogenomics and Personalized Medicine γ-Secretase Substrates and their Implications for Drug Development in Alzheimer's Disease
Current Topics in Medicinal Chemistry The Growth Hormone Secretagogue Receptor (Ghs-R)
Current Pharmaceutical Design Alpha-2 Agonists: Can they Modify the Outcomes in the Postanesthesia Care Unit?
Current Drug Targets Reversal of Multidrug Resistance by Natural Substances from Plants
Current Topics in Medicinal Chemistry β -TrCP Dependency of HIV-1 Vpu-Induced Downregulation of CD4 and BST-2/Tetherin
Current HIV Research Novel Aceclofenac-L-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability
Current Drug Delivery Aspirin: A Potential Therapeutic Approach in Pancreatic Cancer
Current Medicinal Chemistry Modulatory Factors Responsible for Neoangiogenesis in Young Patients with Long-Standing Diabetes Mellitus Type 1
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Neuroprotection Abilities of Cytosolic Phospholipase A2 Inhibitors in Kainic acid-induced Neurodegeneration
Current Drug Targets - Cardiovascular & Hematological Disorders